PF4 ‐associated immune thrombocytopenia and thrombosis ( PITT )—More than heparin and vaccines
British Journal of Haematology · 2025
DOI: 10.1111/bjh.20125 ↗Kurz gefasst
Fallbericht in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Michael Makris. Beteiligte Einrichtung: School of Medicine and Population Health, University of Sheffield, Sheffield, UK. Hauptthemen laut MEDLINE: Platelet Factor 4, Heparin, Purpura, Thrombocytopenic, Idiopathic, Cytomegalovirus Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A young woman presented with portal vein thrombosis and thrombocytopenia and developed further extensive thrombosis following treatment with heparin. Despite no previous heparin exposure, she was found to be strongly positive for anti‐platelet factor 4 (PF4) antibodies. She had acute cytomegalovirus (CMV) infection and a monoclonal gammopathy. Commentary on: Nicolson et al. Anti‐PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT‐like and VITT‐like characteristics. Br J Haematol 2025; 206:1737‐1742.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
ORCID-Profile: Michael Makris
Zitieren
APA
Makris, M. (2025). PF4 ‐associated immune thrombocytopenia and thrombosis ( PITT )—More than heparin and vaccines. British Journal of Haematology. https://doi.org/10.1111/bjh.20125
Vancouver
Makris M. PF4 ‐associated immune thrombocytopenia and thrombosis ( PITT )—More than heparin and vaccines. British Journal of Haematology. 2025. doi:10.1111/bjh.20125
BibTeX
@article{Makris2025,
author = {Makris, Michael},
title = {PF4 ‐associated immune thrombocytopenia and thrombosis ( PITT )—More than heparin and vaccines},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.20125}
}
EUVIMED